PubRank
Search
About
Metronomic Chemotherapy With Capecitabine for Pancreatic Cancer
Clinical Trial ID NCT03959150
PubWeight™ 0.00
‹?›
🔗 Visit the ClinicalTrials.gov page for NCT03959150
Top papers
Rank
Title
Journal
Year
PubWeight™
‹?›
1
Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: a randomized trial.
J Clin Oncol
1997
29.02
2
Pancreatic cancer. Adjuvant combined radiation and chemotherapy following curative resection.
Arch Surg
1985
7.14
3
Pancreatic ductal adenocarcinoma: long-term survival does not equal cure.
Surgery
2012
3.87
4
Adjuvant chemotherapy with gemcitabine and long-term outcomes among patients with resected pancreatic cancer: the CONKO-001 randomized trial.
JAMA
2013
3.46
5
Effect of adjuvant chemotherapy with fluorouracil plus folinic acid or gemcitabine vs observation on survival in patients with resected periampullary adenocarcinoma: the ESPAC-3 periampullary cancer randomized trial.
JAMA
2012
2.88
6
Adjuvant treatments for resected pancreatic adenocarcinoma: a systematic review and network meta-analysis.
Lancet Oncol
2013
2.58
7
Adjuvant chemotherapy of S-1 versus gemcitabine for resected pancreatic cancer: a phase 3, open-label, randomised, non-inferiority trial (JASPAC 01).
Lancet
2016
2.22
8
Comparison of adjuvant gemcitabine and capecitabine with gemcitabine monotherapy in patients with resected pancreatic cancer (ESPAC-4): a multicentre, open-label, randomised, phase 3 trial.
Lancet
2017
1.46
9
Evaluation of adjuvant chemoradiation therapy for ampullary adenocarcinoma: the Johns Hopkins Hospital-Mayo Clinic collaborative study.
Radiat Oncol
2011
1.10
10
Updates in Gastrointestinal Oncology - insights from the 2008 44th annual meeting of the American Society of Clinical Oncology.
J Hematol Oncol
2009
0.97
11
Outcomes following resection of pancreatic cancer.
J Surg Oncol
2012
0.89
12
Update on the management of pancreatic cancer: surgery is not enough.
World J Gastroenterol
2015
0.89
13
Blood circulating tumor DNA for non-invasive genotyping of colon cancer patients.
Mol Oncol
2015
0.76
14
Potentially Curable Pancreatic Cancer: American Society of Clinical Oncology Clinical Practice Guideline Update.
J Clin Oncol
2017
0.75
Next 100